Wolfgang Hammerschmidt

12.0k total citations · 1 hit paper
136 papers, 9.5k citations indexed

About

Wolfgang Hammerschmidt is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, Wolfgang Hammerschmidt has authored 136 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Oncology, 65 papers in Epidemiology and 38 papers in Immunology. Recurrent topics in Wolfgang Hammerschmidt's work include Viral-associated cancers and disorders (98 papers), Cytomegalovirus and herpesvirus research (60 papers) and Lymphoma Diagnosis and Treatment (28 papers). Wolfgang Hammerschmidt is often cited by papers focused on Viral-associated cancers and disorders (98 papers), Cytomegalovirus and herpesvirus research (60 papers) and Lymphoma Diagnosis and Treatment (28 papers). Wolfgang Hammerschmidt collaborates with scholars based in Germany, United States and United Kingdom. Wolfgang Hammerschmidt's co-authors include Bill Sugden, Dagmar Pich, Henri‐Jacques Delecluse, Reinhard Zeidler, Andreas Moosmann, Aloys Schepers, Christoph Mancao, Georg W. Bornkamm, Markus Kalla and Alexander Buschle and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Wolfgang Hammerschmidt

132 papers receiving 9.3k citations

Hit Papers

Genetic analysis of immortalizing functions of Epstein–Ba... 1989 2026 2001 2013 1989 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes
    1989 473 citations Wolfgang Hammerschmidt, Bill Sugden profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang Hammerschmidt Germany 59 6.5k 3.7k 2.6k 2.4k 2.1k 136 9.5k
Henri‐Jacques Delecluse Germany 55 6.8k 1.0× 2.9k 0.8× 2.0k 0.8× 3.2k 1.3× 1.5k 0.7× 153 8.9k
Shannon C. Kenney United States 56 6.6k 1.0× 3.1k 0.8× 2.3k 0.9× 2.2k 0.9× 1.6k 0.7× 145 8.5k
Kenzo Takada Japan 56 6.6k 1.0× 2.2k 0.6× 2.7k 1.0× 2.6k 1.1× 2.2k 1.0× 158 9.3k
Erle S. Robertson United States 57 6.4k 1.0× 4.0k 1.1× 1.4k 0.5× 2.1k 0.9× 2.8k 1.3× 226 9.3k
Richard Longnecker United States 60 7.3k 1.1× 5.4k 1.4× 3.9k 1.5× 3.4k 1.4× 2.4k 1.1× 202 13.0k
David A. Thorley‐Lawson United States 59 8.1k 1.2× 3.6k 1.0× 3.6k 1.4× 3.7k 1.6× 2.4k 1.1× 115 12.2k
Blossom Damania United States 52 5.0k 0.8× 3.7k 1.0× 2.9k 1.1× 1.2k 0.5× 2.9k 1.4× 188 9.2k
Bill Sugden United States 59 8.7k 1.3× 4.2k 1.1× 2.1k 0.8× 3.3k 1.4× 4.2k 2.0× 147 13.4k
Riccardo Dolcetti Italy 48 4.8k 0.7× 1.4k 0.4× 2.1k 0.8× 3.2k 1.4× 1.6k 0.7× 255 8.3k
Nancy Raab‐Traub United States 71 11.1k 1.7× 3.4k 0.9× 3.0k 1.2× 4.4k 1.8× 3.5k 1.6× 167 15.0k

Countries citing papers authored by Wolfgang Hammerschmidt

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Hammerschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Hammerschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Hammerschmidt more than expected).

Fields of papers citing papers by Wolfgang Hammerschmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Hammerschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Hammerschmidt. The network helps show where Wolfgang Hammerschmidt may publish in the future.

Co-authorship network of co-authors of Wolfgang Hammerschmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Hammerschmidt. A scholar is included among the top collaborators of Wolfgang Hammerschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Hammerschmidt. Wolfgang Hammerschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pich, Dagmar, et al.. (2023). Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model. Vaccines. 11(3). 540–540. 4 indexed citations
2.
Wange, Lucas E., et al.. (2022). EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus–infected B cells. Proceedings of the National Academy of Sciences. 119(30). e2200512119–e2200512119. 23 indexed citations
3.
Pich, Dagmar, Manuel Albanese, Paul R. Wratil, et al.. (2022). Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test. PNAS Nexus. 1(2). 5 indexed citations
4.
Albanese, Manuel, et al.. (2021). Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection. PLoS Pathogens. 17(4). e1009117–e1009117. 18 indexed citations
5.
Bouvet, Mickaël, Takanobu Tagawa, Manuel Albanese, et al.. (2021). Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus. mBio. 12(2). 40 indexed citations
6.
Buschle, Alexander, Xia Wu, Stefan Krebs, et al.. (2021). Human ORC/MCM density is low in active genes and correlates with replication time but does not delimit initiation zones. eLife. 10. 25 indexed citations
7.
Buschle, Alexander, Paulina Mrozek-Górska, Filippo M. Cernilogar, et al.. (2021). Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation. Nucleic Acids Research. 49(6). 3217–3241. 20 indexed citations
8.
Deng, Yun, Bithi Chatterjee, Kyra D. Zens, et al.. (2021). CD27 is required for protective lytic EBV antigen–specific CD8+ T-cell expansion. Blood. 137(23). 3225–3236. 27 indexed citations
9.
Günther, Johannes, Alexander Buschle, Christine Göbel, et al.. (2021). Structural basis of DNA methylation-dependent site selectivity of the Epstein–Barr virus lytic switch protein ZEBRA/Zta/BZLF1. Nucleic Acids Research. 50(1). 490–511. 17 indexed citations
10.
Mourão, André, Piero Giansanti, Anita Murer, et al.. (2021). PLK1‐dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV‐infected mice. EMBO Reports. 22(12). e53007–e53007. 7 indexed citations
11.
Buschle, Alexander & Wolfgang Hammerschmidt. (2020). Epigenetic lifestyle of Epstein-Barr virus. Seminars in Immunopathology. 42(2). 131–142. 74 indexed citations
12.
Mrozek-Górska, Paulina, Alexander Buschle, Dagmar Pich, et al.. (2019). Epstein–Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection. Proceedings of the National Academy of Sciences. 116(32). 16046–16055. 139 indexed citations
13.
Mrozek-Górska, Paulina, Alexander Buschle, Takanobu Tagawa, et al.. (2019). BZLF1 interacts with chromatin remodelers promoting escape from latent infections with EBV. Life Science Alliance. 2(2). e201800108–e201800108. 35 indexed citations
14.
Albanese, Manuel, Takanobu Tagawa, Mickaël Bouvet, et al.. (2016). Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8 + T cells. Proceedings of the National Academy of Sciences. 113(42). E6467–E6475. 127 indexed citations
15.
Tagawa, Takanobu, Manuel Albanese, Mickaël Bouvet, et al.. (2016). Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. The Journal of Experimental Medicine. 213(10). 2065–2080. 105 indexed citations
16.
Jochum, Simon, et al.. (2012). RNAs in Epstein–Barr virions control early steps of infection. Proceedings of the National Academy of Sciences. 109(21). E1396–404. 65 indexed citations
17.
Moosmann, Andreas, Iris Bigalke, Johanna Tischer, et al.. (2010). Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. Blood. 115(14). 2960–2970. 173 indexed citations
18.
Kalla, Markus, et al.. (2009). AP-1 homolog BZLF1 of Epstein–Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proceedings of the National Academy of Sciences. 107(2). 850–855. 130 indexed citations
19.
Tierney, Rosemary J., et al.. (2007). Epstein-Barr Virus Exploits BSAP/Pax5 To Achieve the B-Cell Specificity of Its Growth-Transforming Program. Journal of Virology. 81(18). 10092–10100. 34 indexed citations
20.
Wendtner, Clemens‐Martin, Christian Kurzeder, Hans Theiß, et al.. (2003). High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus–free recombinant Epstein-Barr virus vectors. Experimental Hematology. 31(2). 99–108. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henri‐Jacques Delecluse Breakdown of academic impact, for papers by Shannon C. Kenney Breakdown of academic impact, for papers by Kenzo Takada Breakdown of academic impact, for papers by Erle S. Robertson Breakdown of academic impact, for papers by Richard Longnecker Breakdown of academic impact, for papers by David A. Thorley‐Lawson Breakdown of academic impact, for papers by Blossom Damania Breakdown of academic impact, for papers by Bill Sugden Breakdown of academic impact, for papers by Riccardo Dolcetti Breakdown of academic impact, for papers by Nancy Raab‐Traub
Rankless by CCL
2026